S
Sana Biotechnology, Inc. (SANA)
NMS – Real Time Price. Currency in USD
3.26
-0.30 (-8.43%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
3.26
-0.30 (-8.43%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Cash reserves $76.1M barely cover the upcoming debt maturities $78.9M
Total current assets $148.7M exceed Total current liabilities $78.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.5) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$33.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.89 | 6.05 | 9.0 | |
| Quick ratio | 1.89 | 5.63 | 9.0 | |
| Debt to Equity | 0.49 | 0.30 | 7.0 | |
| Debt to Assets | 0.18 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -28M | -31M | -15M | -13M | -13M |
| Operating Income | -269M | -326M | -271M | -191M | -191M |
| Net Income | -269M | -283M | -267M | -244M | -244M |
| EBITDA | -241M | -295M | -256M | -178M | -178M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 22.91 | 5.5 |
| Next quarter | N/A | 58.97 | 5.5 |
| Current year | N/A | 35.53 | 5.5 |
| Next year | N/A | 3.05 | 2.5 |
| Weighted average score | 4.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -39.54 | -31.24 | -13.71 | 3.3 |
| Y/Y | 999 | -19.87 | 0 | 29.59 | 5.5 |
| 3y average | 999 | 3.06 | 19.04 | 20.6 | 8.3 |
| 5y average | 999 | 1.75 | 16.1 | -4.47 | 5.8 |
| Weighted average score | 5.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |